Co-Diagnostics Capital Expenditures (CapEx) Growth & History (CODX)

Co-Diagnostics's capital expenditures (capex) was $700,047 for fiscal 2025.

View full Co-Diagnostics company overview

Co-Diagnostics annual capital expenditures (capex) history

Co-Diagnostics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$700,047−$48,305−6.45%
20242024-12-31$748,352−$616,954−45.19%
20232023-12-31$1.4M−$62,206−4.36%
20222022-12-31$1.4M$758,049+113.23%
20212021-12-31$669,463−$104,934−13.55%
20202020-12-31$774,397$661,151+583.82%
20192019-12-31$113,246$71,910+173.96%
20182018-12-31$41,336−$87,970−68.03%
20172017-12-31$129,306$117,065+956.34%
20162016-12-31$12,241

Co-Diagnostics capital expenditures (capex) trends

Over the last five fiscal years, Co-Diagnostics's capital expenditures (capex) decreased from $774,397 to $700,047, a change of −$74,350. The latest reported quarter, Q2 2026, shows $18,281.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Co-Diagnostics source filings ↗

Community posts

It’s quiet here.

No posts about CODX yet. Start the conversation.

Write the first post